Pharmacological
Research
Communications,
Vol. 8, No. 2, 1976
111
ABSOLUTECONFIGURATIONAND BIOLOGICAL ACTIVITY OF VIMINOL STEREOISOMERS ' D. Della ZAMBONS.p.A. Received
In
15September
the
a novel
last
with
robenzyl-pyrryl on the other
G. Benelli
and A. Sassi
Research Laboratories,
Bresso-Milan,
Italy
1975
few years our interest
compound (Fig.
derivative
Bella,
the group
(Teotino
1)
has been concentrated
which may be considered
ethanol
chain bearing,
on one and Della
side, Bella,
a pyrrylethanolamine
as substituents,
and
the
on viminol,
the o-chlo-
di-sec.butylaminic
1967; Teotino
et al.,
group
1972).
CH I 3
,
0
\
EHoHmCH-N2tiH-C2H5 2
N I
FiPure 1 - Molecular structure of viminol: -2-yl]-2-di-sec.butylamino-ethanol. I+:\ = asymmetric center) In et
al.,
previous 1973;
&j-C
l-Cl-(2-chlorobenzyl)-pyrrol-
experiments
we demonstrated
Della
and Lualdi,
Bella
H 2.5
both in animals (Della
1974)
and
Bella
in humans (Buzzelli
0) Paper presented by D. Della Bella at the Satellite Symposium on Acute Effects of Narcotic Analgesics (VI Internat. Congress of Pharmacology), Nokkala-Helsinki, July 18-20, 1975.
112
Pharmacological
et
al.,
Frigerio,
1970;
Monafo,
1971) that
however
in
quite
contrast
different,
the
the
test
of
in
set
known
all
of motility
adone
characterized
the
motor
In rats,
morphine,
to
after
is
admin-
methadone and viminol.
rats
viminol
adopting
has been shown
by morphine and meth-
a very marked ipermotility:
response
is
by using different
in naive rats
treated
properties:
liability.
and Davis (1967) it
in chronically
and
compounds viminol
obtained
is presented
by
analgesic
animal “species.
the compounds tested:
elicited
appear
different
Vol. 8, MO. 2, 1976
1970; Martinetti
narcotic
by the results
up by Babbini
The responses
conditions
most
is supported
the same pattern
istration
et al.,
possesses marked central
to
approaches
motility
that
Communications,
showing only a very poor addiction
This conclusion experimental
Martinetti
1974;
viminol
Research
in the same
absent (Babbini
et al.,
1973). Furthermore, narcotic jumping the
it
is
analgesics, behaviour
stronger
to pentazocine
wellknown the
(Saelens
that
challenge et
al.,
in
with
mice repeatedly naloxone
1971).
and propoxyphene,
compounds, the response to viminol
is shown in Table 1
animals.
which are, as wellknown, is even less
with
produces the typical
As it
is provoked in morphinized
response
treated
(Della
In comparison
poorly
Bella
addicting
and Lualdi,
1974). Table 1 - Jumping test
DRUGS
(Saelens et al.,
Total dose mg/kg i.p.
1971):
Z-day test
NALOXONE (100
results.
mg/kg i.p.) INCIDENCE
No. mice jumped/No.tested
CHALLENGE percentage
Viminol
1%
IO/73
13.7
Morphine
400
83/85
97.7
Pentazocine
170
6/20
30
d-Propoxyphene
114
7/36
19.5
Pharmacological The
Research
results
suppression
obtained
procedure
and subcutaneous
signs
appear not
clearly
monkeys
illustrated
administration
unchanged
substitute
Table
Vol. 8, No. 2, 1976
in morphinized
are
oral
does
Communications,
for
2 - Single
adopting
the
in Table
of viminol,
or even more
113
severe.
single
dose
2: following
the
14-hour
The conclusion
both
withdrawal
is
that
viminol
morphine. dose
suppression
test"
NUMBEROF MONKEYS
in morphinized
monkeys.
14-HOUR WITHDRAWAL SIGNS
FROM
I unchanged unchanged more severe more severe more severe ,rnore severe
15 20
HRC HRC MCV MCV MCV MCV
$6) The tests were performed by the Huntingdon Research Centre (BRC), England, and by the Medical College of Virginia (MCV), USA, whose cooperation we gratefully aknowledge. Considering pharmacological lack
profile
of addiction
has been allow
the
the
cessarily
liability
central
on the
other,
why and how does
splitting
of pharmacological
evidence analgesic
arising
from
activity
the
on one side,
the
question
we asked
ourselves
the
viminol
molecular
structure
properties
usually
we
consider
ne-
interdependent.
evaluation
has been
of the
oms (they
there
obtained
individual
in many natural
no1 molecule
anolic
experimental
of viminol,
following:
The answer
found
contradictory
this
is
the
substituted
connecting aminic
butyl
groups.
group
can possess,
group
Considering as it
the
isolation
stereoisoners
and synthetic
are asterisk
chain
after
central
recurrence
marked the
1):
substituted
that
other, the
the
the
than
the
asymmetric
in
present
has been the
in
in the
atom of
vimi-
carbon the
on one side
recur
carbon
2, the
also
is
group
others
As it
one asyrmnetric
first
pyrryl
shown in Fig.
viminol.
analgesic,
of more
in Fig.
on the
is
of
and the pharmacological
ateth-
and two
the
R or S configuration,
the
secondary
sec.butyl the
114
Pharmacological
following the
three
viminol
(Fig.
configurated
molecule:
the
couples
Research of
R,R , or the
Communications,
stereoisomers
Vol. 8, PJo. 2, 1976
may be presented
S,S or further
still
the
by
R,S(S,R)
3).
CH3 \ N / C2H5
S-configuration
R-configuration Figure
Figure As the isomers
2 - Absolute
3 - Absolute
ethanolic may exist,
and R,R,S
j S,S,R
chain
also
presenting and S,S,S
configuration
configuration contains the
of N-sec.butyl
of viminol an asymmetric
following
; and at last
R,S,S
stereoisomers. carbon
absolute
groups.
atom,
configuration:
and R,S,R
(Chiarino
six
stereoR,R,R et al.,
Pharmacological
in press).
Research
It
Communications,
seemed reasonable
ical
activities
sult
of mutual interaction
isomers,
of viminol
as determined
well as by their The results ferent
to us to assume, then,
between the
by their
that
differently
relative
the pharmacolog as the re-
configurated
concentration
stereo-
in the
mixture
as
potency for a given effect.
of the pharmacological
investigations
performed
into
the dif
can be summarized as follows.
The R,R configurated and repeated
physical
115
racemate we found have to be regarded
relative
stereoisomers
single
Vol. 8, No. 2, 1976
stereoisomers
administration:
exhibit
agonistic
analgesia
activities
and catalepsy,
both
tolerance
on and
dependence.
The S,S configuration
produces
of the R,R stereoisomers,
effects
which are antagonistic
be they acute (analgesia),
to those
or chronic
(physical
dependence). The S,R or Meso compounds have the property pendence producing
capacity
These experimental some general
structural
features
not present
evident
veral
important
not a rigid may lie tic
appear to be of interest
considerations
and narcotic similarity
ves such as morphinans,
but a flexible
activity. either
structure,
is present
instead
considered
an isosteric
synaptic
its
gical
so that
derivative
activity
may proceed from a possible
N-alkyl properties
of the
two
radicals presented
As to how, therefore,
sec.butyl
amines; radicals
is responsible by the viminol
molecule
is
amine alipha-
nitrogen;
molecular
se
amine group
b) a tertiary
of phenylethanolamine
molecule does
On the contrary,
the substituted
ring;
between
wellknown derivati
a) the viminol
d) the viminol
events promoted by biogenic
configuration
the viminol
of the basic heterocyclic
carbon atom is present;
that
out:
because
existing
morphine or its
can be pointed
quaternary
gestion
relation
In fact
to
in the same plane as the aromatic
nitrogen
ferent
about the
particularly
benzomorphans or phenylmorphans.
differences
de-
of the R,R stereoisomers.
results
they allow
of opposing the physical
c)
structure allowing
interference
e) the different
no may be sug-
the
with the absolute
and not the presence of dif-
for the quite
different
pharmacolg
stereoisomers.
the R,R stereoisomer
of viminol
may interact
with
116
Pharmacological
the
neuronal
receptor
macologic It
effects,
appears
a precise Casy Perhaps
it
allow
to the
a proton
the
functional
However,
for
macological
effects,
ically
aiming
the
at
Firstly
a better
these
cending ic like at a-l.,
interneurons
tract
to
the
morphine, spinal 1975)
inhibitory
the
level
the
(Kitahata
and/or control
course
that
lamina
findings
nucleus
been done
strictly
in the
reladonor
or
case of vimL
sites
involves
a very
dif
stex
some experiments
more
specif-
correlation
biological
between
evidence
about
the As
activity.
afferences
through
thalamus.
vi-
it
the
al.,
a reinforcement and Takagi,
in the
after
well-
the
as-
analgesics,
a direct 1975;
stem (Satoh
is
spinothalam-
The narcotic
et
influence
for
activation:
Le Bars
the
activity.
responsible
through
high
of phar-
at least,
of
1974;
effect
have
is known,
types
V interneurons
brain
mo-
specific
of the
peripheral
the
viminol
a proton
in producing
in part
from
very
and
molecule.
the
revealed
V interneurons
lamina
that
by Beckett
as it
membrane
some experimental
et al.,
an indirect
pha;
bonds.
and the
posteroventral depress
1975),
for
not either
to undertook
are, of
Bella,
the viminol
with
neuronal
understanding
on the
transmission
be of
structure
configuration
of R,R stereoisomers known,
provided
experimental
to obtain
the
(1965):
compounds,
and different
we decided
we tried
suitable
by Portoghese
to the
viminol
stereochemical
model
may also
as our previous
eoselectivity
a more
but
binding groups
Vol. 8, No. 2, 1976
initiating
out
for
that
It
as worked
be hypothesized
of different
group.
for
shown (Della
model
one proposed
stereospecific
ferent
cannot
(structure,
acceptor
no1 the
a receptor
fitting
morphine
required
as previously
to
the
complex
Communications,
an open question.
evident,
may be suggested is
the
really
morphine,
binding
minol
is
quite
for
it
could
ted
it
accommodation
(1954)
lecule
to form
Research
effect
Della
Bella
et
of descending 1971)
have
been
postulated. Our experiments cal
level:
el using experiment determine
the glass the the
extracellular
unitary
microelectrodes
filled
electrophoretic
injection
microelectrode
tip
cat,
recordings with
position.
were
3 Mol KCl. of pontamine The results
spinal
section
made at the At the blue
at
cervi-
lumbar
end of
leveach
was performed
obtained
are
shown
to
Pharmacological from
Fig.
taneous
4:
the
afferent
venous the
Research
Communications,
responses fibers
evoked appear
administration:
by peripheral
practically
naloxone
is
117
Vol. 8, No. 2, 1976 stimulation
abolished
able
of the
after
to reverse
small
viminol
quickly
cu-
R 2 intra-
and completely
inhibition.
EF (pinch)
240 i 220. 200. 180. 160-
-
140. P h 5 r
10 5ec.
120. 100.
0’
4
control
1 mg/kg
Figure
4 - Lamina ment.
The direct appears
i.v.
V interneuron
influence
of the
confirmed
that
only
activity
different the
--1 min. after
4 I NALOXONE 0.1 mg/kg
15 min. after
after
viminol
stereoisomers
R
is
R,R configuration
is
ix.
2
and naloxone
treat-
shown in Table provided
with
3: it
agonistic
effects. It
is
interesting
mer is vo - have
more
than
out
the
R1 is
in Fig.
figurated is
active
shown that
illustrated
It
to point
that
also
at the
R1 enantiomer:
at least
5 shows the
20-30
spinal
analgesic times
antagonistic
less effect
level assays
the
R
2 performed
active.
The
produced
by the
enantioin vi-
experiment S,S con-
S2 stereoisomer. evident
in reversing
that the
the
S2 intravenous
depressant
effect
administration by the
R
2
isomer.
is
rapidly
Considering
effective that
this
118
Pharmacological
Research
Table 3 - Morphine and viminol stereoisomers activation of lamina V inter-neurons.
3C Morphine R
-w Viminol
4
SC Vznol
R 1 S 1 S2
-',L::Viminol
Meso
on nociceptive
depression strong depression
28
2
Vol. 8, No. 2, 1976
INFLUENCE
11
*:- Viminol
%+ Viminol
influence
No. OF REGISTERED INTERNEURONS
DOSE mg/kg i.v.
COMPOURDS
Communications,
weak depression
4
no
effect
3
no
effect
6
no
effect
i as hydrochloride X- as p-hydroxybenzoate
EF (pinch)
160. 140. Y f 0 Y ,P
I;... maec.
120. 100. 60. 60. 40. 20. O-
,
control
Figure
.
4
I ’ VIMINOL 1 w/kg
5 - Lamina V interneuron ment.
c
.
Rp
T VIMINOL
i.v.
2 mglkg
15 min.
activity
after
after
,
viminol
,
.
5 min. after
S2
i.v.
stereoisomers
treat
Pharmacological
Research
interaction,
Communications,
as in the case of morphine and naloxone,
as consequent to the displacement stereoisomer, following
we then studied
the procedure
results
Vol. 8, No. 2, 1976
obtained
of R2 from the specific
their
described
binding
of viminol
VIMINOL ISOMERS
-:)
As it phine,
to the synaptosomal
The preliminary
and
AL
y.
DRUGS"
(ti)
40
MORPHINE
70
METHADONE
30
> 1000
PENTAZOCINE
50
' 2500
PROPOXYPBENE
1000
7
' 1000
Pert and Snyder (1973)
in the order of magnitude
logical
S2
fractions
stereoisomers
appears the RDso values of R,R stereoisomersare
R2 values
by
in the Table 4.
Table 4 - Synaptosomal binding morphine-like drugs.
L
receptors
by Pert and Snyder (1973).
by us are reported
R1 R 2 S 1 S 2 R,S (Meso)
could be interpreted
are not, potency.
of pentazocine
the R aild 1 in good agreement with their pharmaco-
on the contrary, As we said before,
spect to R2. But the unexpected the S2 stereoisomer,
10 times those of may
and methadone:
Rl is 20-30 times less active
result
is the very low affinity
which we found able to reverse
in
re-
shown by
the depressant
effect
of R on the spinal interneurons. Its affinity appears even lower 2 that of Sl and Meso compoundswhichwe found completely ineffective
than in &
vivo experiments. Now, if
we accept that
is consequent
on its
the influence affinity
on the lamina V interneurons
to a specific
receptor,
by R2
then the suppres
sion of such influence
the
S2 affinity
the
experimental results
by S could be possible only in the case that 2 to the same specific receptor was higher. On the contrary, evidence proves that R2 affinity
from its
is much higher.
ability
to
displace
to the
binding
site,
as
naloxone from synaptosomal fraction,
it
120
Pharmacological
It is reasonable nation tion
of this
finding
is the occurrence and antagonist
interaction
To obtain
further
testinal
The influence
structures
and its
ously illustrated Kosterlitz,
displayed
evaluation
results
experimental
it
is quite
the R,R configurated
but also
of
and the mecha-
between the viminol
of their
agonists
Kosterlitz
we obtained
conditions
evident
effects
stimc
and antagonists
features
ste
on the in-
electrically
on these
have been
and Lees, 1964;
previ-
Waterfield
are summarized in the
that
usually
values
and
activity
activity
analgesic
hot plate test (mice)a
tail flick test (ratsIb
stereoisomers.
acetic acid stretthing test (mice)c
R1
z 20
17.5 (11.7-26.2)
(14.624.8)
R 2
1.15 (0.8-1.5)
0.71 (0.49-1.03)
(1.4Z)
5
> 40
’ 40
‘> 40
S
> 40
> 40
> 40
’ 40
> 40
P- 40
2 R,S(Meso)
Eddy et al. (1950) D'Amour and Smith (1941) Koster et al. (1959)
properby
being the most active.
ED5o (mg/kg s.c.) VIMINOL ISOMERS
dose 50 in
is possessed only
the R2 enantiomer
of viminol
following
of the effective
adopted to test
the analgesic
stereoisomers,
Table 5 - Analgesic
a) b) c)
interac-
and types of attack.
nervous terminals
The Table 5 shows the comparative
different
expla-
1975).
The experimental tables.
existing
by narcotic
1957;
site,
sites
dependence on stereochemical (Paton,
a satisfactory
about the nature
and interactions
smooth muscle and cholinergic
lated.
ties:
evidences
the in vitro
Vol. 8, No. 2, 1976
not only of a molecular
from different
experimental
we undertook
that
at the same binding
resulting
nism both of the activity reoisomers
Communications,
to suppose, in our opinion,
between agonist
a functional
Research
Pharmacological
Research
Communications,
12 ‘1
Vol. 8, No. 2, 1976
Both the S,S and the Meso compounds have to be considered fective.
When we tried
acetylcholine
release
compounds tested rated
to correlate
possess an inhibitory
activity,
found between the resting by electrical
and influence stereoisomers.
has been provoked
IN VITRO ACh RELE E % (GUINEA-PIG z3uM) ID5o (mol. cont.) -6 10 8 x IO-7
I‘ 20
1 x
1.15
s1
> 40
s2
> 40 ’ 40
R,S(Meso) Eddy et al.
(1950);
both on the acetylcholine stereoisomers values,
tor responses:
appear to be active
finding
is,
dependence between reduction of the electrically
As regards the influence by viminol unexpectedly
stereoisomers,
existing
between the inhibitory
release and the motor responses.
the S,S stereoisomers this
-8 7 x 10 -8 5 x 10 8 x IO-7
b) Paton (1957)
The Table 7 shows the correlation
reoisomers.
only with antagonistic
of acetylcholine
2
erties
the
on the acetylcholine
IN VIVO ANALGESICACTIVITY (HOT PLATE TEST IN MICE)a JD5o bdkg s.c.)
R 1 R
tration
all
stimulation.
VIMINOL ISOMERS
figurated
on the
the S,S configu-
compounds. No difference
release and the release
Table 6 - Analgesic activity release by viminol
a)
not only that
but that
as we have demonstrated
appear to be the most active
inef-
to the influence
(Table 6), we found unexpectedly
stereoisomers , provided
properties,
these properties
practically
potency
While the R,R COE
about at the same molar concen-
are clearly
in our opinion,
of acetylcholine
less effective against
on the mo-
a necessary inter-
release and inhibitory
prop-
provoked motor responses. of naloxone on the intestinal the results
obtained
naloxone is able to antagonize
motor inhibition
(Table 8) demonstrate
that
both the R,R and the Meso ste-
122
Pharmacological
Research
Communications,
Vol. 8, No. 2, 1976
Table 7 - Influence of viminol stereoisomers on the acetylcholine release and the motor responses of guinea-pig ileum to electrical stimulation. .VIMINOL ISOMERS
ACh RELEASElD MOL. CONC. 50
R 1 R 2
1 x 10 8 x 10-7
MOTORRESPONSES ID MOL. CONC. 50
-6
-6
1.3 x 10 2.4 x 10-7
-8 7 x 10 -8 5 x 10 8 x lo -7
3 s2 R,S(Meso)
-6
1.7 x 10 1.8 x 10-6 -6
1.4 x 10
Table 8 - Influence of naloxone and CaC12 on the inhibitory activity of viminol stereoisomers on guinea-pig ileum responses to electrical stimulation.
VIMINOL ISOMERS
NALOXONE (75 Ml
R 1 R2 S 1 s2 R,S(Meso)
Naloxone does not modify, S,S stereoisomers. R,R stereoisomers
reversal
reversal
reversal
unchanged
reversal
unchanged
reversal
reversal
reversal
on the contrary,
No antagonistic
from the works of Nutt
effect
the inhibition
influence
have been detected.
calcium on the inhibitory
of the S,S
Table 8 also
of viminol
is antagonized,
define
moment how important
not competitively, this
correlation
produced by
the
compounds on
the
shows the influence
stereoisomers.
(1968) and Kakunaga et al.
phine activity at this
reversal
of
It is wellknown
(1966) that
also the mor
by calcium:
it
is to explain
is hard to the mecha
Pharmacological
Research
Communications,
Vol. 8, No. 2, 1976
nism by which morphine and viminol
reduce the electrically
provoked intest&
nal motility. We think
however that
could be a suggestive complex formation
a chelation
hypothesis.
only requires
the amine group on one side, steric
orientation
Figure
As it
difference
6, if
stereoisomers the
calcium
between the cation
group on the other,
and
than the
groups has only a secondary role.
viminol-calcium
complex formation.
and acetylcholine
release are strictly
becomes obvious why we did not find
between the differently
New experiments
bonds
and the hydroxyl
As the calcium ions concentration then it
is shown in Fig.
coordination
of the sec.butyl
6 - Hypothetical
terdependent,
of calcium by the viminol
configurated
are in progress
to clarify
viminol this
ig
any substantial
stereoisomers.
problem.
CONCLUSIONS The conclusions logical
activities
of our studies
on viminol
are the following:
molecular
configurations
and bio-
124
1)
Pharmacological
First
of all,
it
and
synthetic
has been proved that, morphine-like
pyrryl-ethanolamine, tagonistic 2)
Research
Communications,
in addition
Vol. 8, No. 2, 1976
to the known natural
compounds, a new molecular
is able to produce both narcotic
structure, agonistic
the and an-
effects.
Like morphine,
at spinal
level
the R,R configurated
mers depress the lamina V interneurons ciceptive
stimulation.
This effect
viminol
stereoiso-
activation
by peripheral
is specifically
antagonized
noby
the
S,S stereoisomers. 3)
The antagonism
by the S,S stereoisomers
of competitive
displacement
reoisomers;
unlike
the R,R
therefore
in our opinion,
be regarded, properties,
(1972),
All viminol release
agonistic
duction
mine the inhibition fact, 6)
there
is no
A non stereospecific reoisomers influence Finally,
be supported,
of electrically correlation
interaction
consideration: structures
as postulated
by
of yet
un-
passive drugs,
only
reduce acetylcholine completely
of
inhibition.
stereoisomers,
that
factor
intestinal
a re
to deter-
motility:
between calcium ions and viminol explanation
the interest
provided
so as to make available
devoid
in
between the two effects.
release.
tools
properties
for the modulation
stimulated
on acetylcholine
also new pharmacological
own
is the only important
as a possible
develop new molecular
with their
for the viminol
is postulated
a general
as provided
produce the strongest
release
clear
not should
S,S stereoisomers,
at least
of acetylcholine
do
free.
activities,
There is no evidence,
of the R,R ste-
antagonists
(R,R , S,S and Meso)
ileum.
in term
The narcotic
and not as indirect,
sites
configurations
by guinea-pig
narcotic
responsible
functions,
able to make the binding
sites.
the "abstinoid"
directly
known physiological
site
compounds the S,S stereoisomers
binding
Villarreal
5)
from the same binding
bind to the synaptosomal
pharmacological
4)
can not be interpreted
of their
to identify,
with narcotic
we need to clarify
inhibitory
study and
properties
not only new therapeutic
ste-
has to
agents,
the structure-activity
but
Pharmacological
Research
relationship,
the mechanism and site
quently,
their
precise
Communications,
125
Vol. 8, No. 2, 1976
of action
of narcotics
and, conse-
value.
REFERENCES BABBINI M. and DAVIS W.M. (1967)
- The Pharmacologist
BABBINI M., GAIARDI M. and BARTOLETTIM. (1973)
9, 219.
- Europ. J. Pharmacol. 2&
137.
BECKETTA.H. and CASYA.F.
(1954)
- J. Pharm. Pharmac. 6, 986.
BUZZELLI G., GRAZZINI M. and MONAFOV. (1970)
- Cur-r. Ther. Res. 12, 561.
CHIARINO D., DELLA BELLA D., JOMMI G. and VENEZIANI C. - J. Med. Chem., in press. D'AMOURF.E. and SMITH D.L.
(1941) - J. Pharmacol.
72, 74.
DELLA BELLA D., FERRARI V., FRIGENI V. and LUALDI P. (1973) Biology 241, 282.
- Nature New
DELLA BELLA D. and LUALDI P. (1974) - Proceedings of the "2nd Congress of the Hungarian Pharmacological Society", Budapest, October 2-5, 1974, in press. DELLABELLAD.,
BENELLI G. and BESSONJ.M. (1975) - Life
DELLA BELLA D. (1975) - Neuropharmacol.
l&
Sci. 17, 73.
in press.
C. and LIEBERMANJ.E. EDDYN.B., FUHRMEISTERTOUCHBERRY macol. 98, 121.
(1950)
- J. Phar-
FRIGERIO G. (1974)
- Minerva Med. -65 (suppl. 12), 687. KAKUNAGA T., KANETOH. and HAN0 K. (1966) - J. Pharmac. Exp. Ther. 153, 134. KITAHATAL.M., sthesiology
KOSAKAY., TAUB A., BONMOSK. and HOFFERTM. (1974) - Ane4l, 39.
KOSTERR., ANDERSON M. and DE BEERE.J. KOSTERLITZH.W. and LEES G.M. (1964)
(1959) - Fed. Proc. l8,
- Pharmacol. Rev. l6,
412.
301.
LE BARSD., ME&TREY D ., CONSEILLERC. and BESSONJ.M. (1975) - Brain Research 98, 261. MARTINETTI L., cd.
lo,
LODOLAE., MONAFOV. and FERRARI8.
(1970) - J. Clin.
Pharma-
390.
MARTMETTI L. and MONAFOV. (1971) NUTT J.G. (1968) - Fed. Proc. 3, PATONW.D.M. (1957) - Brit.
- Int.
J. Clin.
Pharmacol. 4, 298.
753.
J. Pharmacol. 12, 119.
PERT C.B. and SNYDERS.H. (1973) - Proc. Nat. Acad. Sci.
(USA) z,
2243.
126
Pharmacological
Research
Communications,
Vol. 8, No. 2, 1976
PORTOGHESE P.S. (1965) - J. Med. Chem. 8, 609. SAELENSJ.K., GRANATF.R. and SAWYER W.K. (1971) - In: ItCommittee on Problems of Drug Dependence", 32nd Annual Meeting, Toronto, February 16-17, 1971, Vol. II, p. 1310. SATOHM. and TAKAGI H. (1971) - Europ. J. Pharmacol. 14, 60. TEOTINOU.M. and DELLA BELLA D. (1967) - Belgian
Patent 698,568.
TEOTINOU.M., DELLA BELLA D., VENEZIANI C. and CHIARINO D. (1972) - Belgian Patent 790,747. VILLARREAL J.E. (1972) - In: "Agonist and Antagonist Analgesic Drugs", Kosterlitz H.W., Collier H.Q.J. Editors, Macmillan, London, p. 73. WATERFIELDA.A. and KOSTERLITZH.W. (1975) - Life
Actions of Narcotic and Villarreal J.E.
Sci. 16, 1787.